Glypican-3-Targeted PET/MR Identifies MRI-Indeterminate Early Hepatocellular Carcinoma in Cirrhosis. Hu W, Li M, Jiang D, Cai X, et al. Clin Nucl Med 2026 Sep 9. doi: 10.1097/RLU.0000000000006695.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu W, Li M, Jiang D, Cai X, et al. Glypican-3-Targeted PET/MR Identifies MRI-Indeterminate Early Hepatocellular Carcinoma in Cirrhosis. Clin Nucl Med 2026 Sep 9. doi: 10.1097/RLU.0000000000006695.
PMID: 42725456